Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors

Chimeric antigen receptor (CAR) T-cell immunotherapy refers to an adoptive immunotherapy that has rapidly developed in recent years. It is a novel type of treatment that enables T cells to express specific CARs on their surface, then returns these T cells to tumor patients to kill the corresponding...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Lele, Zhang, Zhengchao, Ren, Zhijian, Tang, Futian, Li, Yumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170155/
https://www.ncbi.nlm.nih.gov/pubmed/34093592
http://dx.doi.org/10.3389/fimmu.2021.687822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170155/
https://www.ncbi.nlm.nih.gov/pubmed/34093592
http://dx.doi.org/10.3389/fimmu.2021.687822

Ejemplares similares